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Abstract Human mitochondria contain a genome (mtDNA) that encodes essential subunits of
the oxidative phosphorylation system. Expression of mtDNA entails multi-step maturation of
precursor RNA. In other systems, the RNA life cycle involves surveillance mechanisms, however, the
details of RNA quality control have not been extensively characterised in human mitochondria.
Using a mitochondrial ribosome profiling and mitochondrial poly(A)-tail RNA sequencing (MPAT-
Seq) assay, we identify the poly(A)-specific exoribonuclease PDE12 as a major factor for the quality
control of mitochondrial non-coding RNAs. The lack of PDE12 results in a spurious polyadenylation
of the 3’ ends of the mitochondrial (mt-) rRNA and mt-tRNA. While the aberrant adenylation of 16S
mt-rRNA did not affect the integrity of the mitoribosome, spurious poly(A) additions to mt-tRNA
led to reduced levels of aminoacylated pool of certain mt-tRNAs and mitoribosome stalling at the
corresponding codons. Therefore, our data uncover a new, deadenylation-dependent mtRNA
maturation pathway in human mitochondria.
DOI: 10.7554/eLife.27596.001
Introduction
The human mitochondrial genome (mtDNA) encodes a subset of the structural polypeptides
required for oxidative phosphorylation (OxPhos). The mitochondrial (mt-) mRNAs are transcribed
and then translated within the mitochondrial matrix by highly specialised machinery. The RNA com-
ponents of the intra-mitochondrial translation system, two mt-rRNAs and 22 mt-tRNAs, are also
expressed from mtDNA. However, all protein components required for mtDNA expression are
encoded by the nuclear genome and, upon translation on cytoplasmic ribosomes, are imported into
mitochondria. In human mitochondria, mature mt-mRNA species carry a non-templated stretch of
poly(A) residues of an average length of 45–55 nucleotides, with the exception of ND6, which does
not contain a poly(A) tail. Adenylation of mt-mRNA is performed by mitochondrial poly(A) polymer-
ase (mtPAP, also known as PAPD1) (Nagaike et al., 2005; Tomecki et al., 2004). Notably, disrup-
tion of RNA polyadenylation in human mitochondria, due to mutations in mtPAP, has been linked to
a neurodegenerative disease (Crosby et al., 2010; Wilson et al., 2014).
During eukaryotic gene expression, polyadenylation of mRNAs is required for export of mature
mRNAs from the nucleus, transcript stability and the ability of mRNAs to be translated. In contrast,
in prokaryotes polyadenylation of RNA species generally serves as a signal for degradation
(Rorbach et al., 2014). For 7 of the 13 human mt-mRNAs (ND1, ND2, ND3, ND4, CytB, COIII, and
ATP6) 3’ polyadenylation is essential for completion of stop codons and, therefore, the open-reading
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frame. However, the requirement for longer poly(A) tails on most mt-mRNAs in human mitochondria
is currently not fully understood.
Previously, ourselves and others have identified phosphodiesterase 12 (PDE12) as a mitochondrial
protein of the exonuclease/endonuclease/phosphate (EEP) family (Poulsen et al., 2011;
Rorbach et al., 2011). Recombinant PDE12 exhibited a 3’fi5’ exoribonuclease activity on poly(A)
homopolymers, and to a lesser extent on poly(U) homopolymers. It also specifically removed poly(A)
tails from synthetic ND1 and COII transcripts, stopping 6–8 nt upstream of the polyadenylation site
(Rorbach et al., 2011). Consistent with the in vitro data, when transgenic PDE12 was overexpressed
in cultured cells poly(A) tails on mature mt-mRNAs were shortened. This shortening of poly(A) tails
led to changes to steady-state levels of mt-RNAs in a transcript-specific manner, with deadenylation
leading to an increase in steady-state levels of some transcripts (e.g. ND1, ND2) and a decrease of
others (e.g. COI, COII). This suggested that the status and extent of polyadenylation of mt-mRNAs
regulates the steady-state level of some mt-mRNAs. In addition, upon prolonged PDE12 overexpres-
sion, and associated loss of mt-mRNA polyadenylation, a general defect in mitochondrial translation
was observed. Interestingly, overexpression of mitochondriallytargeted cytosolic deadenylase PARN
also caused strong inhibition of intra-mitochondrial protein synthesis (Wydro et al., 2010). Although
this may indicate that polyadenylation is also required for translation of mt-mRNAs (with the excep-
tion of ND6), analysis of mt-mRNAs revealed that loss of polyadenylation was accompanied with a
loss of stop codons for transcripts lacking 3’ UTRs, as their completion relies on polyadenylation.
This removal of the stop codons complicated the assertion that shortening of poly(A) tails led
directly to the observed translation defect. Additionally, ablation of a mitochondrial RNA-binding
protein LRPPRC in a mouse model resulted in deadenylation of mt-mRNA with no universal effect on
translation, suggesting that translation of some mammalian mitochondrial transcripts can be effec-
tive even in the absence of a poly(A) tail (Ruzzenente et al., 2012).
In order to further investigate the role of PDE12 and RNA polyadenylation in mitochondrial gene
expression, we ablated PDE12 in human cells. Unexpectedly, the absence of the PDE12 poly(A)-spe-
cific exoribonuclease did not have any effect on the mitochondrial messenger RNA poly(A) tail
length, nor its stability. Instead, we observed that PDE12 was required to remove spurious adenyla-
tion of the 3’ end of 16S mt-rRNA and mt-tRNAs. While the aberrant adenylation of 16S did not
affect the integrity of the mitochondrial ribosome (mitoribosome), next-generation RNA sequencing-
assisted ribosome profiling of PDE12 knock-out cells revealed mitoribosome pausing at specific
codons leading to a strong mitochondrial translation defect. Subsequent analysis revealed substan-
tially lower levels of certain aminoacylated mt-tRNAs as a result of spurious adenylation of their 3’
ends. We conclude that a unique deadenylation pathway exists in human mitochondria, which is
required for maintaining the proper pool of mt-tRNAs by removing 3’ end poly(A) tails after promis-
cuous adenylation.
Results
PDE12 is required for efficient mitochondrial gene expression
In order to investigate the effects of the absence of PDE12, we produced a gene knockout in
HEK293 cells using genome editing by a zinc finger nuclease (ZFN). We generated a heterozygous
cell line which contained a single indel at the PDE12 gene locus (PDE12+/ ) and a PDE12 /  cell
line containing two indels, which produced protein-terminating frameshifts. Western blotting con-
firmed the absence of PDE12 protein expression (Figure 1A and Figure 1—figure supplement 1A–
B). We observed a reduction in the steady-state levels of marker OxPhos subunits for complexes I, III
and IV in PDE12 /  suggesting a combined defect in OxPhos complex synthesis and/or assembly in
the absence of PDE12 (Figure 1A). Consistent with this, the cellular respiration was impaired in cells
lacking PDE12 (Figure 1B). We further confirmed the compromised OxPhos performance by cultur-
ing cells in media containing galactose as the sole carbon source, forcing them to rely more on mito-
chondrial ATP production. Under these conditions, the growth rate of PDE12 /  cells was greatly
reduced as compared to controls (Figure 1C). We also detected a reduction in mitochondrial trans-
lation in PDE12 /  as compared to either PDE12+/+ or PDE12+/  (Figure 1D). Quantification of a
subset of [35S]Met-labeled translation products indicated that longer mitochondrial translation prod-
ucts were affected to a greater degree than the shorter products (Figure 1E). This indicated that
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either the initiation of longer mt-mRNAs is specifically affected or that the process of translation
elongation is perturbed.
In order to confirm the specificity of phenotypes observed in the PDE12 /  cell line, we gener-
ated four further cell lines where PDE12 was disrupted. Similarly to the initially analysed clonal cell
line (Figure 1), in these independently constructed PDE12 knock-out cell lines we also observed
reductions in the steady-state levels of OxPhos components and in the rate of mitochondrial transla-
tion (Figure 1—figure supplement 1). Next, we used the Flp-In T-REx system to allow inducible
expression of either the wildtype (WT), a catalytically-inactive mutant form of PDE12 (E351A)
(Figure 1A) or mutants lacking the mitochondrial targeting sequence (D16 and D23) that are not
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Figure 1. PDE12 is essential for efficient mitochondrial translation. (A) Western blotting for steady-state levels of OxPhos components in PDE12+/+,
PDE12 ± and PDE12 /  cells, and in PDE12 /  expressing either wild-type PDE12 or the E351A catalytic mutant at increasing expression levels. (B)
Basal oxygen consumption of PDE12+/+ and PDE12 /  cells, and PDE12 /  cells expressing either wild-type PDE12 or E351A. Mean values ± SEM
are shown, n = 3. *p<0.05, ***p<0.001 with Student t-test relative to PDE12+/+. (p values: [+/+] vs. [+/ ] p=0.0141; [+/+] vs. [ / ] p=0.00134; [+/+] vs.
[ /  + WT] p=0.12; [+/+] vs. [ /  + E351A] p=0.0144). (C) Growth curve of PDE12+/+, PDE12+/  and PDE12 /  cells, and PDE12 /  cells
expressing either PDE12 wild-type or E351A cultured in DMEM containing 0.9 g/L galactose. Representative experiment is shown where each cell line
was plated in quadruplicate (mean ± 1 SD). (D) Metabolic labelling of mitochondrial translation products with [35S]-methionine in PDE12+/+, PDE12+/
  and PDE12 /  cells, and in PDE12 /  cells expressing either wild-type PDE12 or E351A for 24 hr at increasing levels. CBS: Coomassie blue stained
gel as loading control. (E) Quantification of a subset of mitochondrial translation products in PDE12+/  and PDE12 /  relative to PDE12+/+using
ImageQuant software. Relative quantification for each polypeptide was plotted against expected length of polypeptide. For COII/III, ND1/ND2 and
COI/ND4 products were quantified together due to proximity of their bands on the gel, and plotted mass is the mean average of both proteins
(mean ± SD; n = 6, for PDE12+/  n = 3, **p<0.01, ***p<0.001). (p values: [+/+] vs. [+/ ]: ATP8 p=0.148, ND4L p=0.407, ND3 p=0.299, COX2/COX3
p=0.263, ND1/ND2 p=0.397, COX1/ND4 p=0.12124, ND5 p=0.08528; [+/+] vs. [+/+]: ATP8 p=0.328, ND4L p=0.058, ND3 p=0.00857, COX2/COX3
p=9.2110 5, ND1/ND2 p=0.00029, COX1/ND4 p=2.0810 5, ND5 p=0.00016.
DOI: 10.7554/eLife.27596.002
The following figure supplement is available for figure 1:
Figure supplement 1. Gene targeting of PDE12 with ZFNs and complementation.
DOI: 10.7554/eLife.27596.003
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imported to mitochondria as confirmed by immunofluorescence analysis (Figure 1—figure supple-
ment 1E). As strong and prolonged overexpression of PDE12 had previously been shown to cause a
defect in mitochondrial gene expression (Rorbach et al., 2011), we employed a range of doxycy-
cline concentrations (0, 0.5, 1.0 ng/ml) in order to titrate levels of PDE12 re-expression. Re-expres-
sion of WT PDE12 cDNA, but not the E351A, D16 and D23 mutants resulted in a rescue of the
steady-state levels of OxPhos subunits, growth phenotypes and intra-mitochondrial translation
(Figure 1A–D, Figure 1—figure supplement 1F). This indicated that catalytically active,
mitochondrially localised, PDE12 is required for efficient mitochondrial gene expression. As the neg-
ative effects on mitochondrial gene expression in PDE12 /  were not accompanied by a decrease
in mtDNA copy (Figure 2—figure supplement 1A), it was concluded that a defect of either mito-
chondrial transcription or a post-transcriptional process was occurring in the absence of PDE12.
Ablation of PDE12 does not change mitochondrial messenger RNA
steady-state level nor poly(A) tail length
We next sought to determine whether alterations to the mitochondrial transcriptome have led to the
mitochondrial translation defect observed in the PDE12 /  cells. As PDE12 had previously been
characterised as a poly(A)-specific mitochondrial exoribonuclease and its overexpression led to a
decrease of poly(A) tail length and altered steady-state level of mt-mRNAs (Rorbach et al., 2011),
we set out to examine the effects of absence of PDE12 on mt-mRNAs. Our previously published
data showed that under conditions of PDE12 overexpression, poly(A) tails on the ND1 and COII mt-
mRNAs were shortened (Rorbach et al., 2011). However, in the absence of PDE12, no significant
change to poly(A) tail length of either ND1 or COII was observed, when assayed either via mitochon-
drial poly(A) tail assay (MPAT) or circularisation RT-PCR (cRT-PCR) (Figure 2A–B). Furthermore, no
change in poly(A) length was observed for all further polyadenylated mt-mRNAs, assessed via north-
ern blotting or MPAT (Figure 2C and Figure 2—figure supplement 1B). Northern blotting also
demonstrated the steady-state levels of all mt-mRNAs were not greatly reduced in PDE12 / 
(Figure 2C and Figure 2—figure supplement 1C). This observation was confirmed by the applica-
tion of RNAseq to determine differential expression of mt-mRNAs in PDE12 /  (Figure 2D). RNA-
seq also confirmed that anti-sense transcripts were not accumulating in PDE12 /  (Figure 2D).
Together these data suggest that neither changes in steady-state level or poly(A) tail length of mt-
mRNAs are likely to be the underlying cause of the severe mitochondrial translation defect observed
in PDE12 /  cells (Figure 1D).
Translating mitoribosomes stall on specific codons in the absence of the
PDE12 deadenylase
We set out to further examine the cause for the mitochondrial translation defect observed in
PDE12 /  cells. Firstly, we performed sucrose-gradient fractionation of PDE12+/+ and PDE12 / 
total cell lysates to determine if mt-mRNAs were correctly loaded on mitochondrial monosomes. We
monitored migration of the 28S small (mt-SSU) and 39S large (mt-LSU) mitochondrial ribosomal sub-
units by western blotting for the mS18b and bL12 mitochondrial ribosomal proteins (MRPs), respec-
tively (Figure 3A). Migration of the mt-SSU and mt-LSU were further confirmed via northern blotting
for the 12S and 16S mt-rRNAs (Figure 3A). This analysis indicated that in both PDE12+/+ and
PDE12 / , the 55S monosome was formed correctly, migrating in fractions 12–15 of the sucrose
gradient (Figure 3A). Northern blotting of mt-mRNAs indicated proper loading of ND1, ND2, COI
and COII transcripts on the 55S monosome in PDE12 /  (Figure 3A), despite severe reduction in
their translation (Figure 1D–E). Combined MRP western blotting and mt-mRNA and mt-rRNA north-
ern blotting suggested accumulation of mitochondrial transcripts in the monosome fractions in
PDE12 /  as compared to PDE12+/+ (Figure 3A). Together with the previous observation that
translation of longer transcripts was more severely compromised (Figure 1E), we next sought to
determine whether the observed accumulation of mt-mRNA in the 55S monosome fractions was the
result of stalled elongating mitoribosomes. We employed mitochondrial ribosome profiling to deter-
mine if elongating mitoribosomes in the PDE12 /  cells were stalling at specific points during trans-
lation. This approach detected highly increased incidence of mitochondrial ribosomal protected
fragments (mtRPFs) centred on AAA and AAG codons (Figure 3B). Similarly to the universal genetic
code, in human mitochondria AAA and AAG encode lysine (Lys). As a control for this analysis, we
Pearce et al. eLife 2017;6:e27596. DOI: 10.7554/eLife.27596 4 of 22
Research article Genes and Chromosomes
performed mitochondrial ribosomal profiling using the DFLP 143B cybrid cell line containing mtDNA,
which carries a homoplasmic deletion between m.7,846 and m.9,748, resulting in the loss of one mt-
tRNA, mt-tRNALys, in addition to a number of mt-mRNA genes (COII, ATP8/6 and COIII)
(Gilkerson et al., 2008). This analysis revealed a comparable profile for accumulation of mtRPFs cen-
tred on AAA and AAG Lys codons as observed for PDE12 /  (Figure 3—figure supplement 1). To
further corroborate the observation of specific mitoribosome stalling on Lys codons, we analysed
the mtRPF profile of the bicistronic ND4L/ND4 mt-mRNA in more detail. Translation of the ND4L/
ND4 transcript results in the synthesis of both encoded proteins through separate initiation events.
Importantly, the ND4L ORF does not contain any Lys codons, while the ND4 ORF contains 11 Lys
codons. While synthesis of the shorter ND4L protein was not significantly altered in PDE12 /  com-
pared to PDE12+/+, translation of the longer ND4 protein was severely reduced in PDE12 / 
Figure 2. Mitochondrial mRNAs are unaffected by absence of PDE12. (A) Radioactive MPAT assay for ND1 and COII transcripts for PDE12+/+ and
PDE12 /  with densitometric profile of tail length determined via ImageQuant. (B) Box plot representing length of 3’ extensions to ND1 and COII
transcripts for PDE12+/+ and PDE12 /  determined via circularisation RT-PCR. PDE12 /  not significant with Student t-test relative to PDE12+/+. (p
values: COX2 p=0.63, ND1 p=0.99). (C) Northern blots of mt-mRNA for PDE12+/+, PDE12+/  and PDE12 / . Nuclear-encoded 18S rRNA was used as
a loading control. Quantification provided in Figure 2—figure supplement 1C. (D) Steady-state levels of mt-mRNAs and mt-mRNA antisense
transcripts for PDE12+/+, and PDE12 /  assessed via RNA-seq.
DOI: 10.7554/eLife.27596.004
The following figure supplement is available for figure 2:
Figure supplement 1. mtDNA copy-number and mt-mRNA are unaffected in PDE12 / .
DOI: 10.7554/eLife.27596.005
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(Figure 1E). The mtRPF profile across the ND4L ORF was highly similar between PDE12+/+ and
PDE12 / , consistent with the lack of any Lys codons and no effect on intra-mitochondrial transla-
tion rate for ND4L (Figure 3C). In contrast, distinct mtRPF peaks were present along the ND4 ORF
in PDE12 / , each corresponding to the location of a Lys codon (Figure 3C). Taken together, we
concluded that in the absence of PDE12 the mitoribosome is assembled correctly, with mitochon-
drial messengers being loaded on the 55S monosome, however, specific mitoribosomal stalling
occurs, predominantly on Lys codons.
PDE12 is required for removal of spurious 3’ adenylation from mt-
tRNAs
Given that we previously characterised PDE12 as a poly(A)-specific exoribonuclease with 3’fi5’
directionality and the observation of specific mitoribosome stalling mainly at Lys codons, we next
decided to examine the 3’ ends of mt-tRNALys in PDE12 /  (Figure 4A). Radioactive MPAT
revealed that in PDE12 /  mt-tRNALys harboured 6–9 nt 3’ extensions (Figure 4B and Figure 4—
figure supplement 1). Expression of catalytically active PDE12, but not the E351A mutant, restored
normal 3’ ends of mt-tRNAs (Figure 4—figure supplement 1). In order to determine the primary
RNA sequence of the 3’ additions to mt-tRNAs in PDE12 / , as well as to determine the transcrip-
tome-wide effect of PDE12 inactivation on all mt-tRNAs, we employed MPAT combined with deep
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Figure 3. Knockout of PDE12 leads to increased stalling events on selected codons on mtDNA-encoded mRNAs. (A) Sedimentation of mitochondrial
ribosomes on 10–30% isokinetic sucrose gradients for PDE12+/  and PDE12 /  cell lines. Fractions obtained for PDE12+/+, and PDE12 /  were
simultaneously analysed by western blotting with antibodies to bL12 (mt-LSU) and mS18b (mt-SSU). Northern blotting was performed using RNA
extracted from each fraction with the indicated probes. Quantification of relative RNA content in each fraction was performed using ImageQuant. (B)
Mean A-site codon occupancy of mitochondrial ribosomal protected fragments (mtRPFs) in the mitochondrial transcriptome of PDE12+/+ and PDE12 /
 . See Materials and methods for further explanation. (C) mtRPF profile for the ND4L/ND4 transcript in PDE12+/+ and PDE12 /  as an example of
increased stalling of mitoribosomes at lysine codons (Note: The ND4L ORF does not contain any lysine codons).
DOI: 10.7554/eLife.27596.006
The following figure supplement is available for figure 3:
Figure supplement 1. Increased stalling events on lysine codons in DFLP cell line.
DOI: 10.7554/eLife.27596.007
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Figure 4. A subset of mt-tRNAs are affected by spurious 3’ adenylation in the absence of PDE12, leading to reduced aminoacylation of specific mt-
tRNAs. (A) Schematic of mt-tRNA structure depicting 3’ extension determined via the radioactive MPAT (b) and MPAT-Seq (c). DB, discriminator base
(B) Radioactive MPAT assay for a subset of mt-tRNAs extracted from PDE12+/+ and PDE12 / . MPAT assay gel profiles were determined using
ImageQuant. (C) Representation of 3’ ends of a subset of mt-tRNAs from PDE12+/+ and PDE12 / , ascertained by MPAT-Seq. Read count shown for
each position is relative to the read count for the corresponding discriminator base (DB) for each mt-tRNA. (D) Box-plot representation of percentage
of mt-tRNAs molecules extended beyond the 3’ CCA addition for all 22 mt-tRNAs, ascertained by MPAT-Seq, for PDE12+/+ and PDE12 /  cells, and
in PDE12 /  cells expressing either wild-type PDE12 or E351A for 24 hr. **p<0.01, ***p<0.001 with Student t-test relative to PDE12+/+. (p values: [+/+]
vs. [ / ] p=0.0089, [+/+] vs. [ /  + WT] p=0.83, [+/+] vs [ /  + E351A] p=2.1410 7). (E) Aminoacylation assay for subset of mt-tRNAs for PDE12+/
+ and PDE12 / . Profiles of aminoacylated mt-tRNAs were determined using ImageQuant. dAAc indicates intentionally deacylated samples.
DOI: 10.7554/eLife.27596.008
The following source data and figure supplements are available for figure 4:
Source data 1. Read count for mitochondrial poly(A) (MPAT) next generation RNA sequencing (MPAT-Seq).
DOI: 10.7554/eLife.27596.009
Figure supplement 1. Radioactive MPAT assay for mt-tRNALys.
DOI: 10.7554/eLife.27596.010
Figure supplement 2. Northern blotting for mt-tRNAs.
DOI: 10.7554/eLife.27596.011
Figure supplement 3. Aminoacylation analysis by sodium periodate oxidation.
DOI: 10.7554/eLife.27596.012
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RNA sequencing (MPAT-Seq). This analysis revealed that the extended 3’ ends of mt-tRNALys (MT-
TK) were the result of spurious adenylation on the 3’ ends of mature mt-tRNA molecules following
CCA addition (Figure 4C). In addition, MPAT-Seq also revealed other mt-tRNAs were affected by
spurious 3’ adenylation in PDE12 / , notable examples being mt-tRNASer(AGY) (MT-TS2) and mt-
tRNAHis (MT-TH), while others remained largely unaffected (Figure 4C, Figure 4—source data 1).
We corroborated the results of MPAT-Seq with conventional radioactive MPAT analysis for selected
mt-tRNAs (mt-tRNA Ser(AGY), His, -Glu, -Met, -Val), revealing a good agreement between the two
approaches (Figure 4B). Global analysis of the 3’ end extended proportion of molecules for each
mt-tRNA revealed a general increase in the proportion of affected molecules in PDE12 / 
(Figure 4D). The proportion of extended mt-tRNA molecules was reduced upon re-expression of
catalytically active PDE12, but not the E351A mutant (Figure 4D). High-resolution northern blotting
showed that oligoadenylation of mt-tRNA in PDE12 /  cells leads to a significant reduction of
mature mt-tRNALys available for aminoacylation, presumably due to the large proportion of mole-
cules extended on the 3’ end (Figure 4B–C). The total steady-state levels of mature and oligoadeny-
lated mt-tRNALys remained unchanged (Figure 4—figure supplement 2). As CCA addition is
required for aminoacylation of mt-tRNAs, it was expected that 3’ extensions to the CCA would result
in a reduction in the proportion of mt-tRNAs available for aminoacylation. Indeed, an aminoacylation
assay based on the usage of low pH to distinguish between the aminoacyl-tRNA and the uncharged
tRNA revealed severe reduction in the overall amount of charged mt-tRNALys (Figure 4E). An alter-
native method for the measurement of tRNA charging based on periodate oxidation confirmed that
only the correctly matured mt-tRNALys could be aminoacylated (Figure 4—figure supplement 3).
We also detected a reduction in the steady-state levels of mature mt-tRNASer(AGY) in PDE12 / 
(Figure 4E, Figure 4—figure supplement 2). However, despite the presence of spurious 3’ adenyla-
tion of mt-tRNAHis in PDE12 / , we did not detect any substantial reduction of the overall level of
aminoacylation of this mt-tRNA (Figure 4E). The amount of charged molecules for other mt-tRNAs
remained unaffected (Figure 4E). Taken together, we concluded that PDE12 is necessary for main-
taining the integrity of the 3’ ends of mt-tRNAs, protecting them from spurious polyadenylation,
with the lack of PDE12 leading to accumulation of dysfunctional mt-tRNAs and as a consequence
reduced levels of mature mt-tRNAs available for aminoacylation and mitochondrial translation.
Spurious poly(A) extensions to 16S mt-rRNA do not affect
mitochondrial monosome assembly
To determine whether the lack of PDE12 led to spurious extensions on other non-coding mtRNAs,
we performed radioactive MPAT (Figure 5A–B) as well as cRT-PCR (Figure 5C–D) for both 12S and
16S mt-rRNAs. Although the 3’ end extensions on 12S were generally heterogenous, they were simi-
lar in PDE12+/+ and PDE12 /  (Figure 5A,C and Supplementary file 1). On the other hand the
extensions to the 3’ end of 16S, while being usually of 4 or 5 nt in length in control PDE12+/+cells,
were significantly longer in PDE12 /  (Figure 5B,D and Supplementary file 1). The cRT-PCR analy-
sis followed by sequencing also confirmed that the 3’ extensions of 16S mt-rRNA were oligoadeny-
late in nature, similar to those on mt-tRNAs in PDE12 /  (Supplementary file 1). Of note, the
analysis of 16S 3’ ends revealed that they frequently (approximately 50%) contained 4–5 nucleotides
encoded by the 5’ terminus of the immediately distal mt-tRNALeu(UUR) (Supplementary file 1), sug-
gestive of alternative endonucleolytic processing or alternative transcription termination within the
mt-tRNALeu(UUR) gene. Earlier sucrose-gradient fractionation indicated no assembly defect of either
subunit of the mitoribosome (Figure 3A), nonetheless, we sought to determine in more detail
whether spurious 3’ adenylation to 16S mt-rRNA had an effect in the assembly of mt-LSU or 55S
monosome. Steady-state levels of both 16S and 12S mt-rRNAs are unaffected in PDE12 / 
(Figure 5E). In addition, steady-state levels of MRPs were not altered in PDE12 / , as determined
by western blotting (Figure 5—figure supplement 1). Of note, mt-LSU components bL17 and bL19
that are adjacent to the 16S 3’ end were unaffected. Therefore, the spurious extensions observed on
16S in PDE12 /  do not appear to affect assembly and/or stability of the mt-LSU.
To investigate whether longer 3’ extensions on 16S impede the formation of the monosome, we
performed 16S MPAT assay for sucrose-gradient fractions known to contain either the free mt-LSU
(fractions 9 and 10) or 55S monosome (fractions 12–15). As the extensions of 16S mt-rRNA in the
mt-LSU of control PDE12+/+cells are almost exclusively either four or five nt (Figure 5B–D), it was
possible that only this specific length is compatible with correct monosome assembly. Therefore, in
Pearce et al. eLife 2017;6:e27596. DOI: 10.7554/eLife.27596 8 of 22
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PDE12 /  there could be selection pressure against mt-LSU which contained longer 3’ extensions
from forming 55S particles. However, 3’ extensions profiles of 16S mt-rRNA are identical for the free
mt-LSU and monosome fractions, indicating that longer 16S 3’ extensions do not impede monosome
formation (Figure 5F). In conclusion, oligoadenylate extensions to 16S mt-rRNA in PDE12 /  do
not seem to negatively impact mitoribosome formation and the stalling of mitoribosome in the
absence of PDE12 is likely to be predominantly caused by mt-tRNAs harbouring poly(A) extensions.
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Figure 5. Spurious adenylation to the 3’ terminus of 16S mt-rRNA in the absence of PDE12 does not affect mitochondrial monosome formation. (A and
B) Radioactive MPAT assay for 12S (a) and 16S (b) mt-rRNAs extracted from PDE12+/+, PDE12+/  and PDE12 /  cells, and for PDE12 /  cells
expressing either wild-type PDE12 or E351A for 24 hr. (C and D) Box-plot representing 3’ extensions to 12S (C) and 16S (D) mt-rRNAs via circularisation
RT-PCR for PDE12+/+ and PDE12 /  cells, and from PDE12 /  cells expressing either wild-type PDE12 or E351A. *p<0.05, ***p<0.001 with Student
t-test relative to PDE12+/+. (p values: 12S: [+/+] vs. [ / ] p=0.013, [+/+] vs. [ /  + WT] p=0.32, [+/+] vs. [ /  + E351A] p=0.84; 16S: [+/+] vs. [ / ]
p=4.610 7, [+/+] vs. [ /  + WT] p=0.53, [+/+] vs. [ /  + E351A] p=5.310 4) (E) Steady-state levels of 12S and 16S mt-rRNAs for PDE12+/+, PDE12
+/  and PDE12 /  determined via northern blotting. (F) Radioactive MPAT assay for 16S mt-rRNA extracted from sucrose-gradient fractions for free
mt-LSU (fractions 9 and 10) and monosome (12-15) for PDE12+/+ and PDE12 /  cells.
DOI: 10.7554/eLife.27596.013
The following figure supplement is available for figure 5:
Figure supplement 1. Structural and western blot analysis of mtLSU.
DOI: 10.7554/eLife.27596.014
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Increased adenylation activity is detrimental for mitochondrial gene
expression
Mitochondrial poly(A) polymerase (mtPAP, PAPD1) is, thus far, the only identified human mitochon-
drial enzyme with a poly(A) polymerase activity. Therefore, we hypothesised that mtPAP contributes
to the spurious adenylation observed on mt-tRNAs and 16S mt-rRNA (Figure 4 and Figure 5). To
determine if an increased expression of mtPAP exaggerates the effect of aberrant 3’ adenylation of
non-coding mtRNAs, we generated cell lines inducibly expressing untagged human mtPAP protein
in either the PDE12+/+ or PDE12 /  backgrounds (Figure 6A). Lengthening of poly(A) tails on ND1
and COII was observed in both PDE12+/+ and PDE12 /  upon mtPAP induction (Figure 6B). The
extent of this increased polyadenylation was similar in PDE12+/+ and PDE12 / , further supporting
the evidence that PDE12 is not required for controlling the length of poly(A) tails of mt-mRNAs. Fur-
ther MPAT-Seq analysis revealed that overexpression of mtPAP in control PDE12+/+ cells led to an
increase in the proportion of mt-tRNAs which carry 3’ extensions, with this increase being compara-
ble to the levels observed in PDE12 /  (Figure 6C and Figure 4—source data 1). However, induc-
tion of mtPAP expression in PDE12 /  led to a greatly increased general proportion of extended
mt-tRNAs (Figure 6C and Figure 4—source data 1), suggesting that PDE12 is required to deadeny-
late the mt-tRNAs erroneously modified by mtPAP. Overexpression of mtPAP also led to further
lengthening of 3’ extensions of 16S mt-rRNA in PDE12 / , but not in PDE12+/+, suggesting that
16S mt-rRNA are protected from aberrant adenylation when PDE12 is present at endogenous level
(Figure 6D). On the other hand, 3’ adenylation of 12S mt-rRNA was affected to a similar extent by
mtPAP overexpression in either PDE12+/+ or PDE12 /  (Figure 6E), supporting the previous
notion of PDE12 not being involved in the maturation of 12S mt-rRNA (Figure 4). Overexpression of
mtPAP in PDE12+/+ led to mild reduction in mitochondrial translation and the steady-state levels of
OxPhos subunits (Figure 6A), However, it is indistinguishable whether this is a result of increased
mt-mRNA poly(A) tail length, 3’ extension to 12S mt-rRNA, increased global 3’ adenylation to mt-
tRNAs, or a combination of these effects (Figure 6D–E). Nonetheless, upon mtPAP overexpression
in PDE12 /  cells the defect in mitochondrial translation and the steady-state levels of the OxPhos
components were exaggerated (Figure 6A). This is consistent with further impairment of mt-tRNAs
and 16S mt-tRNA 3’ ends by spurious polyadenylation when PDE12 is absent (Figure 6C–D), provid-
ing an additional support for the essential role of PDE12 in the deadenylation of mitochondrial non-
coding RNAs upon incorrect modification of their 3’ ends.
Discussion
In mammalian mitochondria, all RNA species are derived from long, polycistronic precursor RNAs
following transcription of mtDNA. This implies that the key regulatory mechanisms governing their
function must operate post-transcriptionally, yet our knowledge of these mechanisms is far from
complete. Here, we discovered a novel role for deadenylation in human mitochondria, which is to
remove promiscuous polyadenylaton from mitochondrial non-coding RNAs. Importantly, we show
that this process is of significance for the maintenance of a proper pool of aminoacylated mt-tRNA,
and in particular mt-tRNALys. One of the major consequences of the lack of deadenylase activity is
the frequent stalling of mitoribosomes, mainly at lysine codons, as revealed by the mitochondrial
ribosome profiling approach, with defective intra-mitochondrial translation and OXPHOS occurring
as a result (Figure 6F).
Regulation of poly(A) tails of mitochondrial messenger RNA
Poly(A) tails play a major regulatory role in determining the stability and translational efficiency of
eukaryotic nuclear-encoded messenger RNAs. Exonucleolytic removal of poly(A) tails (deadenylation)
is the rate-limiting step in mRNA decay in the cytosol, with the majority of deadenylation activity
contributed by the Ccr4-Not and Pan2-Pan3 complexes (Passmore and Taatjes, 2016). However,
herein our comprehensive characterisation of mitochondrial messenger RNAs (Figure 2 and Fig-
ure 2—figure supplement 1) did not reveal any appreciable changes in poly(A) tail or stability of
mt-mRNAs in the absence of the PDE12 deadenylase, previously shown to localise to human mito-
chondria (Poulsen et al., 2011; Rorbach et al., 2011). This strongly suggests that PDE12 is not
involved in the maintenance and function of mt-mRNA in normal physiological conditions. It is
Pearce et al. eLife 2017;6:e27596. DOI: 10.7554/eLife.27596 10 of 22
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Figure 6. Increased adenylation activity is detrimental to mitochondrial gene expression. (A) Western blotting for steady-state levels of OxPhos
components and mtPAP (top). Mitochondrial translation products were labelled with [35S]-Met in PDE12+/+ and PDE12 /  cells with either
endogenous or overexpressed levels of mtPAP (bottom). (B) Radioactive MPAT assay for ND1 and COII extracted from PDE12+/+ and PDE12 /  cells
with either endogenous or overexpressed levels of mtPAP. MPAT assay gel profiles were determined using ImageQuant. (C) Box-plot representation of
percentage of mt-tRNAs molecules extended beyond the 3’ CCA addition for all 22 mt-tRNAs, ascertained by MPAT-Seq, for PDE12+/+ and PDE12 /
  cells with either endogenous or overexpressed levels of mtPAP. **p<0.01, ***p<0.001 with Student t-test relative to PDE12+/+. (p values: [+/+] vs. [+/
+ + mtPAP] p=0.053, [+/+] vs [ / ] p=0.0089, [+/+] vs [ /  + mtPAP] p=5.5210 11). (D and E) Radioactive MPAT assay for 16S (D) and 12S (E) mt-
rRNAs extracted from PDE12+/+ and PDE12 /  cells with either endogenous or overexpressed levels of mtPAP. MPAT assay gel profiles were
determined using ImageQuant. (F) Model of PDE12 function. Polycistronic precursor RNA is endonucleolytically processed, liberating the individual mt-
tRNA transcripts, which undergo post-transcriptional maturation (nucleotide modifications, CCA addition) before being aminoacylated with a cognate
amino acid for use in mitochondrial translation (green). In the case of some mt-tRNAs a spurious poly(A) tail is added by mtPAP, preventing
aminoacylation, leading to mitoribosome stalling during mitochondrial translation and to OxPhos defect as a consequence (red). Deadenylation by
PDE12 removes spurious polyadenylation on mt-tRNAs restoring the properly matured pool of mt-tRNAs available for aminoacylation (green). Note:
The role of PDE12 in the processing of mt-rRNA not included.
DOI: 10.7554/eLife.27596.015
The following figure supplement is available for figure 6:
Figure supplement 1. The role of PDE12 in maturation of mt-tRNATyr.
DOI: 10.7554/eLife.27596.016
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possible that there are alternative deadenylases regulating the length of poly(A) tails on human mito-
chondrial protein-coding transcripts. Further studies will be required to elucidate how the length of
poly(A) tails is controlled in human mitochondria.
The role of deadenylation in the biogenesis of mitochondrial tRNA
During tRNA biogenesis, the nucleolytic removal of the 5’ leader and the 3’ trailer does not usually
produce the complete tRNA and additional maturation steps of their ends are required. Of the most
widespread is the post-transcriptional template-independent addition of CCA at the tRNA 3’ end.
Furthermore, all tRNAs are subjected to extensive post-transcriptional nucleotide modifications, with
mammalian mt-tRNAs harbouring approximately 7% of mt-tRNA chemically modified nucleotides by
dedicated, nDNA-encoded enzymes (Powell et al., 2015b; Suzuki and Suzuki, 2014). The energetic
expenditure by the cell to achieve the full maturation of tRNAs, is presumably one of the reasons
why their half-life is generally longer as compared to messenger RNA (Deutscher, 2006). This might
also justify the existence of tRNA repair mechanism described for other systems; it is advantageous
for the cells to repair a partially damaged mt-tRNA rather than re-synthetize and subject it to multi-
step maturation. Enzymes responsible for the basic tRNA maturation processes have also been
reported to be involved in tRNA repair after damage (Phizicky, 2008). For example, it has been sug-
gested that the 3’ 5’ reverse RNA polymerase, Thg1, normally involved in the synthesis of G-1 in
tRNAHis, has a role in repair of truncated RNA 5’ ends (Jackman and Phizicky, 2006). Also, dedi-
cated enzymes such as RNA ligases (Nandakumar et al., 2008) or demethylating enzymes
(Ougland et al., 2004) can directly neutralise the damage to tRNA. Our results herein indicate that
mechanisms of maintaining the integrity of tRNA via the deadenylation of matured mt-tRNAs exist in
mammalian mitochondria and involve the exoribonuclease PDE12. In this context, the role of PDE12
can be considered not only as a part of the mt-tRNA maturation pathway, but also as a component
of mt-tRNA quality control, with a role in the 3’ end repair upon aberrant polyadenylation. It remains
to be established whether PDE12-assisted deadenylation of aberrantly polyadenylated mt-tRNAs
also plays a regulatory role for mt-tRNA pools. It has been shown that polyadenylation helps to reg-
ulate levels of functional tRNAs in E. coli (Mohanty and Kushner, 2013). Increased expression of the
bacterial poly(A) polymerase, PAP I, leads to the rapid polyadenylation of mature tRNAs, reducing
the fraction of aminoacylated tRNAs and, therefore, limiting levels of functional tRNAs for protein
synthesis. In light of our results, it is possible that mitochondrial polyadenylation by mtPAP may con-
trol the levels of functional mt-tRNA by acting on their 3’ ends and that PDE12 might be an impor-
tant element of such regulatory pathway.
In the eukaryotic nucleus, the TRAMP complex (Trf4/Air2/Mtr4), has been shown to function in
marking nuclear non-coding RNAs with oligoadenylation which acts as a docking site for nuclear exo-
some degradation (Anderson and Wang, 2009). This prokaryote-like approach functions to destabi-
lise unrequired nuclear RNAs, including hypomodified initiator tRNAMet (Wang et al., 2008), in
addition to other non-coding RNAs such as abnormally processed ribosomal RNAs. Hypothetically,
PDE12 could function in a similar manner in the complete turnover of aberrantly matured molecules
from the mt-tRNA pools in human mitochondria, with the oligoadenylation observed herein function-
ing as a signal for degradation. However, following PDE12 knockout, we observed no changes in
overall steady-state level of total mt-tRNA pools, despite a proportion of some mt-tRNA species car-
rying oligoadenylation (Figure 4—figure supplement 2). This would suggest that the purpose of the
oligoadenylation is unlikely to be a signal for complete turnover of the molecule in human
mitochondria.
The promiscuous polyadenylation activity in human mitochondria
Our results suggest that mitochondrial poly(A) polymerase, mtPAP, despite being critical for mito-
chondrial gene expression through maturation of mt-mRNAs (Bratic et al., 2016; Crosby et al.,
2010; Wilson et al., 2014), is a promiscuous enzyme. Although we cannot exclude any other, as yet
unidentified, mitochondrial poly(A) polymerase being involved in spurious mtRNA adenylation, here
we show that overexpression of mtPAP causes increased levels of aberrantly polyadenylated mtRNA,
with the effect being more pronounced in the absence of PDE12 (Figure 6). Interestingly, the levels
of spurious polyadenylation and its functional effects vary between the different mt-rRNA and mt-
tRNA species. While 12S mt-rRNA was not found to be susceptible to promiscuous mtPAP activity in
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the absence of PDE12, 16S mt-rRNA contained abnormal 3’ end extensions. Nonetheless, the
extended 16S mt-rRNA remained functional (Figure 5). Similarly, selectivity of spurious adenylation
towards different mt-tRNAs was observed, with mt-tRNALys, -Ser(AGY) and –His being the most affected
species. Despite comparable levels of aberrant 3’ end polyadenylation of these three mt-tRNAs
detected by the radioactive MPAT and MPAT-Seq (Figure 4B–C), high-resolution northern blotting
(Figure 4—figure supplement 2) revealed that spurious adenylation actually affects mt-tRNALys to a
greater extent. This discrepancy is likely to stem from the intricacies of the MPAT assays (Figure 4B–
D). As the MPAT assays require reverse transcriptase to read through post-transcriptionally modified
bases, the measurements of mt-tRNA adenylation might not be accurate, specifically by over-repre-
senting the extent of 3’ modification of unmodified molecules relative to that of mature mt-tRNAs.
Therefore, the result of the MPAT assays may not exactly reflect the proportion of adenylated mole-
cules in the total pool of each mt-tRNA species.
The steady-state levels of mature mt-tRNALys and mt-tRNASer(AGY) were substantially decreased,
with the levels of mt-tRNAHis available for aminoacylation remaining comparable to the control
(Figure 4E). Notwithstanding with equally diminished pools of aa-mt-tRNALys and aa-mt-tRNASer
(AGY), mitoribosome stalling was predominately detected on Lys codons. The difference in mitoribo-
somal stalling on Lys and SerAGY codons might be explained by the relative percentages of their
occurrence in mtDNA-encoded ORFs. The SerAGY codon is the second least frequently occurring
coding triplet and accounts for 1.4% of all mtDNA codons, whereas Lys occurs with a frequency of
2.5%.
Other cellular roles of PDE12
Recently, PDE12 has been proposed to act in the maturation of mt-tRNATyr. In human mtDNA, the
mt-tRNATyr and mt-tRNACys genes overlap by one nucleotide at their 3’ and 5’ termini, respectively
(Fiedler et al., 2015). During endonucleolytic processing, therefore, an ‘A’ residue, which is shared
between the two mt-tRNAs, is missing from the mature form of one of the mt-tRNA species (Fig-
ure 6—figure supplement 1). There have been conflicting reports, based on in vitro study, regard-
ing the exact nature of the endonucleolytic processing of the mt-tRNATyr-mt-tRNACys junction in
human mitochondria, where cleavage results either in the loss of the mt-tRNATyr discriminator base
(DB), producing a complete mt-tRNACys molecule (Reichert et al., 1998), or in the retention of the
DB by mt-tRNATyr (Rossmanith et al., 1995). It has also been recently proposed that alternative
processing at this site may occur, resulting in pools of complete and incomplete species of each mt-
tRNA (Fiedler et al., 2015). According to this model, the 3’ end of a pool of mt-tRNATyr would need
to be repaired via adenylation to provide the DB, with mtPAP performing the 3’ adenylation of mt-
tRNATyr that need subsequent trimming. Based on in vitro reconstitution experiments, PDE12 and/
or the mitochondrial RNase Z (ELAC2) have been proposed to trim the polyadenylated mt-tRNATyr
precursor leaving the ‘A’ at the DB position for the subsequent CCA addition (Figure 6—figure sup-
plement 1). However, our radioactive MPAT and MPAT-Seq assay in control and PDE12 /  cells
revealed no changes in the mt-tRNATyr 3’ end maturation, suggesting that either PDE12 is not
involved in this process in living cells or there is substantial redundancy in the mechanisms of mt-
tRNATyr biogenesis (Figure 6—figure supplement 1).
PDE12 has also been proposed to play a role in the 2-5A system functioning in cellular anti-viral
defence. Upon viral infection, the production of interferons (IFNs) is stimulated which act to induce
expression of 2’ 5’-oligoadenylate synthetases (2’ 5’-OASs). 2’ 5’-OASs catalyse the synthesis of
5’ triphosphorylated 2’ 5’-linked oligoadenylate polyribonucleotides (2-5As) from ATP. Accumula-
tion of these 2-5As leads to the activation of latent RNase L which, when activated, degrades viral
RNA (Wreschner et al., 1981). PDE12 has been suggested to control the cellular levels of 2-5As by
catalysing their degradation (Johnston and Hearl, 1987; Kubota et al., 2004; Wood et al., 2015).
However, as yet, the role of the 2-5A system has not been characterised in human mitochondria,
being predominantly based in the cytosol and nucleus, implying that a putative extra-mitochondrial
PDE12 pool would have to exist. However, our previous study indicated exclusive mitochondrial
localisation of this protein (Rorbach et al., 2011), which was confirmed in this work (Figure 1—fig-
ure supplement 1). Also, the PDE12 variants without the MTS, which localise in the cytosol, did not
rescue the depletion in OxPhos subunits in the PDE12 /  cells (Figure 1—figure supplement 1),
supporting the notion that mitochondrially localised PDE12 is required for its function in mtDNA
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gene expression. The prior assignment of PDE12 as having a role in the 2-5A system, therefore,
would require further research.
Concluding remarks
In summary, we have assigned a novel molecular function for PDE12 in the deadenylation-dependent
maturation of mitochondrial non-coding RNAs. We have also uncovered several other features of
post-transcriptional regulation of human mitochondrial gene expression, including, for example, the
promiscuity of mitochondrial poly(A) polymerase (mtPAP) and the tolerance of several non-coding
mtRNAs for spurious, non-templated poly(A) extensions (e.g. 16S mt-rRNA or mt-tRNASer(AGY)).
There is recent increasing evidence that perturbation of mtDNA gene expression is often involved to
human respiratory chain disorders (Nicholls et al., 2013; Powell et al., 2015a; Van Haute et al.,
2016, 2015), neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS) (Wang et al.,
2016) or viral infection (Karniely et al., 2016). In this context, our research provides important new
knowledge and molecular tools (e.g. mitoribosome profiling and MPAT-Seq) to study these pro-
cesses, which will help to understand the pathophysiology of these diseases and will be instrumental
in designing future mechanism-based treatments.
Materials and methods
Materials
For a comprehensive list of antibodies, vectors and oligonuclotides used in this study please refer to
accompanying Supplementary file 2 and 3.
Cell lines and culture conditions
The Flp-In T-RExTM HEK293T cell line (purchased from Invitrogen) allows for the generation of stable,
doxycycline-inducible expression of transgenes by FLP recombinase mediated integration. This sys-
tem was used to generate PDE12 /  cell lines, which inducibly expressed PDE12.Strep2.Flag
(PDE12.FST2) and the E351A catalytic mutant (E351A.FST2). The E351A point mutation affects a
putative magnesium-binding residue and severely compromises the activity of PDE12, as character-
ised previously (Rorbach et al., 2011). In addition, PDE12+/+ and PDE12 /  cell lines were pro-
duced which inducibly express mitochondrial poly(A) polymerase (mtPAP). Human embryonic kidney
cell lines (HEK293-Flp-In T-REx; HEK293T) were cultured in DMEM (Dulbecco’s modified eagle
medium) supplemented with 10% (v/v) tetracycline-free fetal bovine serum (FBS), 2 mM Glutamax
(Gibco), 1 x Penicillin/Streptomycin (Gibco), 100 mg/ml Zeocin (Invitrogen) and 15 mg/ml Blasticidin
(Invivogen) at 37˚C under 5% CO2 atmosphere. The cell line was regularly (3–4 months) tested for
mycoplasma using LookOut Mycoplasma PCR Detection Kit (Merck). Twenty-four hours prior to
transfection cells were split to 10-cm plates in culture medium lacking selective antibiotics, grown to
80–90% confluence and transfected with the transgene-specific pcDNA5/FRT/TO construct and
pOG44 using Lipofectamine 2000. Twenty-four hours after transfection, the selective antibiotics
hygromycin (100 mg/ml, Invitrogen) and blasticidin (15 mg/ml) were added, and selection medium
was replaced every 3–4 days.
To generate the PDE12+/  and PDE12 /  cell lines, HEK293T were transiently transfected to
express a pair of CompoZr ZFNs (Sigma-Aldrich), which selectively targeted the PDE12 gene locus
at exon 1 (Figure 1—figure supplement 1). HEK293T cells were electroporated with pZFN1 and
pZFN2 using Cell Line Nucleofector (Lonza) and buffer kit V (Lonza) applying program A-023. 72 hr
following transfection, cells were single-cell cloned into 96-well plates and screened by Sanger
sequencing to identify clones harboring indels in PDE12. Biallelic modification, and therefore loss of
PDE12 protein expression, was confirmed via western blotting.
Human 143B osteosarcoma (HOS) cell line, for the localization of the PDE12.FST2 variant trans-
genes, was cultured in DMEM containing 2 mM Glutamax, 10% FBS and 1 x Pencillin/Strepomycin
(Gibco) at 37˚C under 5% CO2 atmosphere. For immunofluorescence experiments, cells were trans-
fected with pcDNA5/FRT/TO-PDE12.FST2 variants using Lipofectamine 2000 according to manufac-
turer’s instructions.
For growth measurements, cells were plated at 1  104 cells/well in 24-well plates and grown
with 0.5 ng/ml doxycycline in glucose-free DMEM containing 0.9 g/L galactose, 10% (v/v) FBS, 2 mM
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Glutamax and 1 x Penicillin/Streptomycin. Cell confluence was measured at 48 hourly intervals using
the IncuCyte HighDefinition Imaging Mode.
Immunodetection of proteins
The immunofluorescence localization of TOM20 and PDE12.FST2 variants in fixed HOS cells were
performed as described previously (Minczuk et al., 2010). Immunofluroescence images were cap-
tured using a Zeiss LSM 880 confocal microscope.
For immunoblot analysis, 10 mg aliquots of total cell lysate protein or equal volumes of gradient
fractions were subjected to SDS-PAGE, wet transferred to PVDF membranes (Millipore), blocked in
5% non-fat milk (Marvel) in PBS for 1 hr and incubated with specific primary antibodies in 5% non-fat
milk in PBS overnight. The blots were then incubated with HRP-conjugated secondary antibodies
(Promega) in 5% non-fat milk in PBS for 1 hr and visualized using ECL or ECL prime (Amersham).
[35S]-methionine labeling of mitochondrial translation products
To label newly synthesised mtDNA-encoded proteins, growth media was replaced with methionine/
cysteine-free DMEM supplemented with 2 mM Glutamax, 110 mg/ml sodium pyruvate and 48 mg/ml
cysteine. Cells were incubated for 2  10 min in this medium before replacement with fresh methio-
nine/cysteine-free DMEM medium containing 10% dialysed FCS and emetine dihydrochloride
(Sigma-Aldrich, 100 mg/ml) to inhibit cytosolic translation. Cells were incubated for 20 min before
addition of 120 mCi/ml of [35S]- methionine (Perkin Elmer). Labelling was performed for 30 min and
cells were washed twice with PBS and cells were pelleted. Cells were lysed and aliquots of samples
(30 mg) were separated on 10–20% Tris-Glycine SDS-PAGE gels. Gels were dried and products were
visualized and quantified with a PhosphorImager system with ImageQuant software.
Measurement of mitochondrial respiration
Cells were seeded at 4.5  104 cells/well in 200 ml growth medium in XF 24-well cell culture micro-
plates (Seahorse Bioscience) and incubated at 37˚C in 5% CO2 for 24 hr. One hour before the assay,
growth medium was removed and replaced with assay medium (low buffered DMEM, 10 mM l-gluta-
mine, 1 mM sodium pyruvate, 5 mM galactose), with one wash of assay medium, and left to stabilise
in a 37˚C non-CO2 incubator. Analysis was performed in quadruplicate using a XF24 Extracellular
Flux Analyzer (Seahorse Bioscience). The wells were sequentially injected with 100 nM oligomycin to
inhibit ATP synthase, 700 nM carbonylcyanide-4-trifluorometho-xyphenylhydrazone (FCCP) to uncou-
ple the respiratory chain, and 200 nM rotenone to inhibit complex I. Oxygen consumption rate
(OCR) was measured for each well every 5 min before and after each injection.
RNA extraction, mRNA northern blotting
Except where stated, all RNA was extracted from HEK293T cell lines with TRIzol reagent according
to manufacturer’s instructions.
For northern blots for mt-mRNAs, 5 mg aliquots of total RNA were resolved on 1.2% MOPS-form-
aldehyde agarose gels (1.2% UltraPure agarose, 0.7 formaldehyde, 1 x MOPS buffer) and transferred
to a nylon membrane in 2x SSC buffer. Membranes were hybridized with either radioactively labeled
PCR fragments or T7 in vitro transcribed RNA probes corresponding to appropriate regions of
mtDNA, exposed to storage Phosphor screens and imaged using a Typhoon scanner.
Radioactive mitochondrial poly(A) tail (MPAT) assay and MPAT-Seq
This method was adapted from that described by (Temperley et al., 2003). 2.5 mg of total RNA was
incubated for 15 min at 4˚C with 40 pmol of LIGN oligonucleotide, which carries a 3’ Spacer C3
modification to prevent concatemerisation. After incubation, ligation was performed in 20 ml reac-
tions using T4 RNA ligase (1x T4 RNA ligase reaction buffer, 10 units T4 RNA ligase (New England
Biolabs), 1 mM adenosine triphosphate, two units Turbo DNase, 40 units RNasin RNase inhibitor) at
37˚C for 3 hr. Each ligation reaction was subjected to phenol:chloroform extraction followed by
sodium acetate/ethanol precipitation of the aqueous phase overnight at  20˚C. Ligated RNA was
pelleted and resuspended in 10 ml nuclease-free wate. 5 ml aliquots of ligation reaction were sub-
jected to reverse-transcription for 60 min at 37˚C using Omniscript reverse-transcriptase (Qiagen)
primed with 10 pmol of ANTI-LIGN oligonucleotide. An aliquot of this reaction (12.5%) was used as
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template in an initial PCR using 15 pmol each of a gene specific Fw1 and ANTI-LIGN oligonucleoti-
des using KOD polymerase. Primers and free nucleotides were removed after 30 cycles using a QIA-
quick PCR purification column. Gene-specific Fw2 primers were designed such that when used for
nested PCR on the products from the initial PCR, in combination with ANTI-LIGN, a product of
exactly 50 bp would be formed for exact cleavage of mt-RNAs with no 3’ modification.
For radioactive MPAT assay, Fw2 primers were 5’ end labelled with [g-32P]-ATP (Hartmann Ana-
lytic) using T4 PNK. A five-cycle nested PCR was performed with 1/6th of the initial PCR purification
using 30 nM each of ANTI-LIGN and radiolabelled Fw2 oligos in a 20 ml standard KOD polymerase
PCR reaction. Products were resolved on 10% polyacrylamide-urea denaturing gels, gels were dried
and exposed to storage Phosphor screen.
For MPAT-Seq, a single PCR was performed with a gene-specific Fw1 and ANTI-LIGN primers for
all 22 mt-tRNAs. PCR products were pooled and used as template to produce Illumina sequencing
libraries via A tailing and ligation of TruSeq adapters from a TruSeq LT kit.
Computational analysis of MPAT-Seq data
MPAT primers were removed with cutadapt (Martin, 2011) and reads longer than 20nt were
mapped using Bowtie2. To ensure that all 3’ ends were mapped, reads were aligned to a reference
genome based on GRCh38, but with 30 additional, uncalled positions (N) on the 3’ end of all mito-
chondrial rRNAs and tRNAs. To further improve alignment of the 3’ ends, mapping parameters ‘-rdg
7,5 and -rfg 7,5 np 0’ were used.
Circularisation RT-PCR assay
5 mg of total RNA was circularized in a 20 ml reaction using T4 RNA ligase (1x T4 RNA ligase reaction
buffer, 10 units T4 RNA ligase (New England Biolabs), 1 mM adenosine triphosphate, two units
Turbo DNase, 40 units RNasin RNase inhibitor) for one hour at 37˚C. Each ligation reaction was sub-
jected to phenol:chloroform extraction followed by sodium acetate/ethanol precipitation of the
aqueous phase overnight at  20˚C. Circularized RNA was pelleted at 20,000 g for 30 min at 4˚C
resuspended in 20 ml nuclease-free water. 5 ml aliquots of the circularisation reaction were subjected
to reverse-transcription across the circularisation junction for 60 min at 37˚C using Omniscript
reverse-transcriptase (Qiagen) primed with 10 pmol of gene-specific reverse oligonucleotide,
according to manufacturer’s instructions. Following reverse transcription, PCR was performed across
the ligation junction using gene specific primers Fw1 and Rv1. For the ND1 and COI transcripts, a
further nested PCR was performed using the Fw2 and Rv2 oligonucleotides after the initial PCR was
purified using QIAquick PCR purification kit. Following PCR, products were cloned using the Zero
Blunt TOPO PCR Cloning Kit for Sequencing. Clones were sequenced using M13 Forward universal
sequencing primer.
RNAseq
For analysis of mitochondrial mt-mRNAs via RNAseq, mitochondria were first isolated according to
(Minczuk et al., 2011). Mitochondrial pellets were resuspended in QIAzol (Qiagen) and RNA was
extracted using the miRNeasy kit with on column DNase treatment (Qiagen).
Library generation was performed using the TruSeq Stranded Total RNA LT kit (Illumina, UK)
according to manufacturer’s instructions. As part of library generation, cytoplasmic and mitochon-
drial ribosomal RNAs were removed using RiboZero Gold. Quality of libraries was assessed with a
D1000 Screentape for TapeStation (Agilent). Libraries were subjected to high-throughput sequenc-
ing using the Illumina MiSeq platform.
Computational RNAseq data analysis
Quality trimming and 3’end adaptor clipping of sequenced reads were performed with Trim_Galore!.
Only reads for which pair-ended reads were both longer than 20 nt were mapped to GRCh38 using
bowtie2 (Langmead and Salzberg, 2012). As cytosolic and mitochondrial ribosomal RNAs were
depleted using RiboZero Gold (Illumina), reads that mapped to 12S or 16S mt-rRNAs were removed
using Samtools (Li et al., 2009). Samtools was also used to create strand-specific files for each sam-
ple. Rsubread was used to generate count tables (Liao et al., 2013) and DESeq2 was used for statis-
tical analysis of differential gene expression (Love et al., 2014).
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Mitochondrial ribosome profiling (MitoRibo-Seq)
For MitoRibo-Seq, parental HEK293 and PDE12 /  cells were treated with 100 mg/ml chloramphen-
icol and 100 mg/mL cycloheximide for 5 min, rinsed with 5 ml of ice-cold PBS, the dishes were sub-
merged in a reservoir of liquid nitrogen for 10 s and transferred to dry ice. Cells were lysed in 400 ml
of lysis buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM MgCl2, 1 mM DTT, 1% Triton X-100,
100 mg/ml chloramphenicol (Alfa Aesar) and cycloheximide (Sigma Aldrich)). Cells were scraped and
lysates clarified by centrifugation for 20 min at 13,000 g at 4˚C.
200 ml aliquots of cell lysates were treated with 7.5 ml RNase 1 (100 units/ml) at 28˚C. The reaction
was layered onto a 10–30% sucrose gradient as described above for ‘Analysis of mitochondrial ribo-
some integrity’. Subsequently, all fractions containing mitochondrial monosomes, ascertained by
western blotting, were pooled and digested with proteinase K (200 mg/ml) for 30 min at 42˚C. RPFs
were recovered by extracting twice with pre-warmed (65˚C) acidic phenol:chloroform and once with
chloroform (1:1, v/v, buffered with 10 mM Tris pH 7.5, 0.1 mM EDTA) followed by ethanol
precipitation.
RPFs (1 mg) were separated on 15% denaturing polyacrylamide gels and RNA species migrating
between 25 and 35 nt were harvested. RNA was eluted from the gel slices and ethanol precipitated.
The RNA samples from above were heated at 80˚C for 2 min, cooled and the 3’ phosphate group
removed using T4 polynucleotide kinase (New England Biolabs) for 2 hr at 37˚C in a 20 ml reaction.
The RNA was concentrated by ethanol precipitation, resuspended in 10 mM Tris-HCl (pH 7.5) and
ligated in a 20 ml reaction overnight at 14˚C to a preadenylated 3’-adaptor using T4 RNA Ligase 2
(New England Biolabs). RNA was precipitated, loaded into a 15% denaturing polyacrylamide gel and
ligated RNA fragments migrating between 48 and 54 nt were excised. The RNA was eluted, precipi-
tated, resuspended as above, and 5’ phosphorylated using T4 PNK in the presence of 1 mM ATP for
2 hr at 37˚C. RNA was concentrated by ethanol precipitation, resuspended in 10 mM Tris-HCl (pH
7.5) and ligated to a 5’ RNA adaptor overnight at 14˚C using T4 RNA Ligase (New England Biolabs).
The fully adapted RNAs were recovered by ethanol precipitation, dissolved in 6 ml 10 mM Tris-HCl
(pH 7.5), and ligated product annealed to an RT primer for 5 min at 65˚C. The RNA was subse-
quently reverse transcribed for 50 min at 55˚C in using SuperScript III according to manufacturer’s
instructions, followed by heat inactivation for 5 min at 85˚C. Standard PCR reactions were used to
prepare amplicons using forward primer RP1 and RPIX as reverse primer, where X is primer number
(1-24). PCR reactions were loaded onto 10% non-denaturing polyacrylamide-TBE gels and products
of ~150 bp were excised from the gel and eluted. These amplicon libraries were ethanol precipitated
and resuspended in 15 ml 10 mM Tris-HCl (pH 7.5).
Ribosomal RNA was depleted from MitoRibo-Seq samples at the library amplicon stage; 12 mL of
the relevant MitoRibo-Seq library was mixed with 4 mL of 4  hybridization buffer (200 mM HEPES
pH 7.5 and 2 M NaCl) and denatured at 98˚C for 2 min. DNA was re-annealed for 5 hr at 68˚C prior
to addition of 2 mL of 10  DSN master buffer and 2 mL of DSN (four units, Evrogen). Digestion was
allowed to proceed for 25 min at 68˚C, before addition of 20 mL 10 mM EDTA and incubation for a
further 5 min at 68˚C. DNA was recovered by a single extraction with phenol–chloroform (1:1, vol/
vol) followed by ethanol precipitation and resuspended in 4 mL 10 mM Tris–HCl pH 7.5. The treated
amplicon library was subjected to another round of PCR (as above) and the resulting library sub-
jected to a second round of DSN treatment.
Resultant Illumina libraries were sequenced using an Illumina NextSeq 500 platform
Computational analysis of MitoRibo-Seq data
Adaptor sequences were trimmed using the FASTX-Toolkit, trimmed reads mapping to rRNA were
discarded, and remaining reads were mapped to mitochondrial mRNAs using bowtie version 1
(Langmead et al., 2009) with parameters -v 2 –best (i.e. maximum two mismatches, report best
match). Histograms in Figure 3C and Figure 3—figure supplement 1B show the positions of the 5’
ends of mtRPFs with a + 17 nt offset to map the approximate A-site, and smoothed with a 3-nt run-
ning-mean filter. To facilitate precise identification of the A-site, only mtRPFs with lengths in the
range 31 to 35 nt and with 5’ ends mapping to the first or third positions of codons were used for
the codon occupancy plots (Figure 3B and Figure 3—figure supplement 1A), and the A-site codon
was assumed to occupy nucleotide positions 16–18 or 17–19, respectively, of such mtRPFs. These
offsets were determined based on analyzing pausing peaks associated with lysine codons in the
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DFLP mutant, as a function of mtRPF length. Regions of CDS that overlap (ATP8/ATP6 and ND4L/
ND4) were excluded due to ambiguous CDS assignment, and mtRPFs with 5’ ends mapping within
15 nt of the start codon or 45 nt of the stop codon were excluded. Within each mt-mRNA CDS,
mtRPF histograms were scaled by the mean density of mtRPFs within that CDS. Then the scaled den-
sity at each A-site codon was summed over all occurrences of that codon species and downweighted
by the number of occurrences of that codon species in the mt-mRNA CDS regions examined.
Analysis of mitochondrial ribosome integrity on density gradients
Cells were lysed in lysis buffer (50 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 20
mM MgOAc). 800 mg of total cell lysates were loaded onto a linear sucrose gradient [2 ml 10–30%
(v/v)] in 50 mM Tris-HCl (pH7.2), 20 mM Mg(OAc)2, 80 mM NH4Cl, 0.1M KCl, 1 mM PMSF and centri-
fuged for 2 hr 15 min at 100,000 gmax at 4˚C (39,000 rpm, Beckman Coulter TLS-55 rotor). Twenty
fractions (100 ml) were collected. 10 ml were used for western blotting and 90 ml was used for extrac-
tion of RNA using TRIzol LS reagent according to manufacturer’s instructions.
Aminoacylation assays
Total RNA was extracted using TRIzol reagent according to manufacturer’s instructions, with the final
pellet resuspended in 10 mM NaOAc at pH 5.0 and kept at 4˚C to preserve the aminoacylation
state. For deacylated control, the pellet was first resuspended in 200 mM Tris-HCl at pH 9.5 and
incubated at 75˚C for 5 min, followed by RNA precipitation and resuspension in 10 mM NaOAc at
pH 5.0. 5 mg RNA was mixed with an equal volume of sample buffer (0.1M NaOAc, pH 5.0, 8M urea,
0.05% bromophenol blue, 0.05% xylene cyanol) and separated on a 6.5% polyacrylamide gel (19:1
acrylamide:bisacrylamide) containing 8 M urea in 0.1 M NaOAc, pH 5.0. The gel was run at 4˚C at
150 V for 1 hr, and then subsequently increased to 500 V until the bromophenol blue reached the
bottom of the gel (~16 hr). The portion of the gel between the xylene cyanol and bromophenol blue
was dry-blotted onto a nylon membrane (Hybond). Following UV cross-linking (0.120 J), the mem-
brane was hybridized with appropriate radiolabelled riboprobes, and imaged with a
PhosphorImager.
Periodate oxidation was performed by incubating total RNA with 50 mM NaIO4 in 100 mM
NaOAc/HOAc (pH 4.8). The samples were incubated at room temperature for 30 min and then
quenched by adding glucose to 100 mM followed by incubation at room temperature for 5 more
minutes. The RNA preparations were subjected to a G25 spin column (GE Healthcare) and then pre-
cipitated with ethanol. For the second step, the precipitated NaIO4-treated sample was spun down
at 12,000 g for 15 min at 4˚C, the supernatant removed and pellet washed in 70% ethanol, spun
down again at 7500 g for 5 min at 4˚C, the supernatant removed, then the pellet resuspended in 1
M lysine pH 7.4 for 1 hr at 45˚C and then passed again through a G25 spin column. To deacylate
tRNAs, samples were resuspended in 50 mM Tris-HCl (pH 9) and incubated at 37˚C for 30 min. The
RNA samples were ethanol-precipitated and subsequently resuspended in water. RNA preparations
not subjected to periodate oxidation were prepared in the same manner except that NaIO4 was
replaced with NaCl. The loss or retention of the 3’ terminal nucleotide was then determined through
PAGE and northern blotting.
Data availability
Sequencing data for MitoRibo-Seq have been deposited in ArrayExpress (http://www.ebi.ac.uk/
arrayexpress) under the accession number E-MTAB-5519.
The RNASeq data was uploaded into GEO under the accession number GSE95351 (https://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE95351).
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